44 Followers on Owler

Innovent Biologics

engages in research and development of monoclonal antibody drugs for cancer and autoimmune diseases... Read more
OverviewCompetitorsFundingInvestmentsNews & Insights

Innovent Biologics

engages in research and development of monoclonal antibody drugs for cancer and autoimmune diseases... Read more
Innovent Biologics Chairman & CEO: Michael Yu

Chairman & CEO

Michael Yu

CEO Approval Rating

90/100

2011

PublicHong Kong Stock Exchange1801

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology
28342836 NAICS listing

Annual Revenue
$3.5B
Employees
4,872
Funding
$1.3B
Investments
1

News

Partnership
Feb 10, 2026
E China News
Innovent, Lilly ink pact for novel drugs

Innovent Biologics Competitors

1Sino Biological
2BeiGene
3Mabworks
4Brii Bio
5Connect Biopharma
6EMD Serono
7TESARO
8Alphamab Oncology
9Immatics
10Lepu
Unlock 12 + competitors

Trending Companies